Package 68001-342-34

Brand: gemcitabine

Generic: gemcitabine
NDC Package

Package Facts

Identity

Package NDC 68001-342-34
Digits Only 6800134234
Product NDC 68001-342
Product ID 68001-342_049982fe-a321-b868-e063-6294a90ae861
Description

1 VIAL, MULTI-DOSE in 1 CARTON (68001-342-34) / 2 mL in 1 VIAL, MULTI-DOSE

Marketing

Marketing Status
Marketed Since 2018-05-25
Brand gemcitabine
Generic gemcitabine
Sample Package No

Linked Drug Pages (1)

GEMCITABINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "049982fe-a321-b868-e063-6294a90ae861", "openfda": {"upc": ["0368001342346", "0368001348362", "0368001359375", "0368001350686"], "unii": ["U347PV74IL"], "rxcui": ["1998783"], "spl_set_id": ["4031017d-d768-46de-8081-476bcb883f5e"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (68001-342-34)  / 2 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "68001-342-34", "marketing_start_date": "20180525"}], "brand_name": "GEMCITABINE", "product_id": "68001-342_049982fe-a321-b868-e063-6294a90ae861", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-342", "generic_name": "GEMCITABINE", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GEMCITABINE", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "100 mg/mL"}], "application_number": "NDA209604", "marketing_category": "NDA", "marketing_start_date": "20180525", "listing_expiration_date": "20261231"}